Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) announced it is targeting completion of enrollment for its BACKBEAT Global Pivotal Trial by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE